×

The Monthly: April 2022

01 Apr 2022 / Corporate research

An efficient reporting system has seen all the listed multinational pharmaceutical companies announcing results for 2021, which has given us the opportunity to update our industry statistics and drug database. This report provides the first snapshot of the global and US rankings of the top 20 drug companies for 2021. Comparisons are made with historical data to show how different company strategies have evolved. 2021 was characterised by a strong rebound in performance following the pandemic-affected year in 2020. Much of the growth was driven by antibody-derived drugs and vaccines for treatment and prevention of COVID-19.

Download the full report

Request a meeting

If you'd like to be introduced to the team at , get in touch.

Request a meeting
Download the full report